Table 2.

Study schedule

	V1	V2	V3	V4	V5
Written informed consent	x
Personal and family history	x
Inclusion and exclusion criteria	x
Randomization	x
Phone calls		x		x
Heel stick blood sampling	x				x
Venipuncture					x
Anthropometric parameters (weight, length, head circumference)	x		x		x
Body composition	x		x		x
Evaluation of onset and severity of atopic dermatitis by means of the SCORAD index	x		x		x
Adverse events	Throughout the study

V1=enrollment ; V2= consumption of the allocated formula for one month; V3= consumption of the allocated formula for two months; V4= consumption of the allocated formula for three months; V5= consumption of the allocated formula for four months.